[Form 4] Sensient Technology Corporation Insider Trading Activity

Rhea-AI Filing Summary

Sensient Technologies Corp. (SXT) filed a Form 4 on 1 July 2025 reporting that director Dr. Mario Ferruzzi acquired 55.116 deferred stock units on 30 June 2025 through the company’s Directors’ Deferred Compensation Plan. Each unit is economically equivalent to one share of common stock and will be issued when the director leaves the board. After this routine award, Ferruzzi’s holdings consist of 7,980.067 common shares held directly, 225.529 shares held indirectly via his spouse’s ESOP account, and 3,103.917 deferred stock units. No common shares were sold, and the transaction involved no cash outlay because it reflects a deferral of board fees rather than an open-market purchase.

Insights

Securities Analyst

TL;DR: Routine 55-share deferred stock award; insignificant to valuation or sentiment.

The filing shows a modest grant of 55.116 deferred stock units to Director Ferruzzi, raising his total deferred balance to about 3.1 k shares. Given SXT’s market capitalization and average daily volume, the dollar value (roughly low four figures) is immaterial. Because the units stem from fee deferral rather than an outright purchase, the signal value is limited. There is no selling pressure and no dilution implication. Overall, the event is neutral for investors.

Corporate Governance Expert

TL;DR: Standard director compensation deferral; governance practice unchanged.

The award is consistent with Sensient’s long-standing deferred compensation framework that aligns director pay with shareholder value over the director’s tenure. No new plan or amendment is introduced, and Ferruzzi remains a non-executive director with ownership well below reporting thresholds that would imply control. From a governance standpoint the filing is procedural, not strategic, and therefore carries no material impact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ferruzzi Mario

(Last) (First) (Middle)

777 E. WISCONSIN AVENUE

(Street)

MILWAUKEE WI 53202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								7,980.067(1)	D
Common Stock								225.529(2)	I	Spouse's ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock	(3)	06/30/2025		A(4)		55.116		(5)	(5)	Common Stock	55.116	$0	3,103.917	D

Explanation of Responses:

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

2. Represents shares held in Issuer's ESOP as of the end of the month immediately preceding this filing.

3. Deferred stock converts to common stock on a one-for-one basis.

4. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.

5. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

	/s/ John J. Manning, Attorney-in-Fact for Dr. Ferruzzi	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did Director Mario Ferruzzi acquire according to the SXT Form 4?

55.116 deferred stock units were credited to Dr. Ferruzzi on 30 June 2025.

Did Mario Ferruzzi sell any Sensient Technologies (SXT) shares in this filing?

No. The Form 4 shows no dispositions; the transaction was an acquisition.

What is Dr. Ferruzzi’s total direct ownership in SXT common stock after the transaction?

He directly owns 7,980.067 common shares.

Why were the deferred stock units issued at a price of $0?

They represent director fee deferrals; no cash changes hands when fees are converted into stock units.

When will the deferred stock units convert into SXT common shares?

The units convert one-for-one upon Dr. Ferruzzi’s termination of service as a director.